Selecting high priority quality measures for breast cancer quality improvement

Medical Care

Volumn 46, Issue 8, 2008, Pages 762-770

  Hassett, Michael J ^a   Hughes, Melissa E ^a   Niland, Joyce C ^b   Ottesen, Rebecca ^b   Edge, Stephen B ^c   Bookman, Michael A ^d   Carlson, Robert W ^e   Theriault, Richard L ^f   Weeks, Jane C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast cancer and medical intervention; Clinical practice guidelines; Quality improvement; Quality measurement

Indexed keywords

HORMONE RECEPTOR;

ALGORITHM; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; MASTECTOMY; MEDICAL PRACTICE; MEDICAL SOCIETY; PATIENT CARE; PHYSICIAN; SCORING SYSTEM; TOTAL QUALITY MANAGEMENT; AGED; BREAST TUMOR; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; HEALTH CARE PLANNING; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PRACTICE GUIDELINE; QUALITY OF LIFE;

AGED; ALGORITHMS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; EVALUATION STUDIES AS TOPIC; FEMALE; HEALTH PRIORITIES; HUMANS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE;

EID: 49649100656     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e318178ead3     Document Type: Article

References (52)

1. Basch P. Quality of health care delivered to adults in the United States. [comment]. N Engl J Med. 2003;349:1866-1868; author reply 1866-1868
2. Kohn LT, Corrigan J, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000
3. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States [see comment]. N Engl J Med. 2003;348:2635-2645
4. Ray-Coquard I, Philip T, de Laroche G, et al. Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network. J Clin Oncol. 2005;23:4414-4423
5. Borenstein J, Badamgarav E, Henning JM, et al. The association between quality improvement activities performed by managed care organizations and quality of care [see comment]. Am J Med. 2004;117:297-304
6. Goldberg HI, Wagner EH, Fihn SD, et al. A randomized controlled trial of CQI teams and academic detailing: can they alter compliance with guidelines? Jt Comm J Qual Improv. 1998;24:130-142
7. Grol R. Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction [see comment]. JAMA. 2001;286:2578-2585
8. Shojania KG, Grimshaw JM. Evidence-based quality improvement: the state of the science. Health Aff. 2005;24:138-150
9. Greenberg A, Angus H, Sullivan T, et al. Development of a set of strategy-based system-level cancer care performance indicators in Ontario, Canada. Int J Qual Health Care. 2005;17:107-114
10. McGlynn EA, Asch SM. Developing a clinical performance measure. Am J Prevent Med. 1998;14:14-21
11. Network ASoCONCC: ASCO/NCCN Quality Measures: Breast and Colorectal Cancers. 2007
12. Winn RJ; National Comprehensive Cancer Network. The NCCN guidelines development process and infrastructure. Oncology (Williston Park). 2000;14:26 -30
13. Malin JL, Asch SM, Kerr EA, et al. Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool. Cancer. 2000;88:701-707
14. Asch SM, Rand Corporation, United States. Agency for Healthcare Research and Quality. Quality ofCare for Oncologic Conditions and HIV: A Review ofthe Literature and Quality Indicators. Santa Monica, CA: Rand Corporation; 2000
15. Neuss MN, Desch CE, McNiff KK, et al. A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative [see comment]. JClin Oncol. 2005;23:6233-6239
16. Forum TNQ. Quality of Cancer Care Measures. Project Steering Committee Meeting; 2005
17. Malin JL, Schneider EC, Epstein AM, et al. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24:626-634
18. Beck CA, Richard H, Tu JV, et al. Administrative data feedback for effective cardiac treatment: AFFECT, a cluster randomized trial [see comment]. JAMA. 2005;294:309-317
19. Grossbart SR. What's the return? Assessing the effect of "pay-for- performance" initiatives on the quality of care delivery [see comment]. Med Care Res Rev. 2006;63:S29-S48
20. Rosenthal MB, Fernandopulle R, Song HR, et al. Paying for quality: providers' incentives for quality improvement [see comment]. Health Aff. 2004;23:127-141
21. Rosenthal MB, Frank RG, Li Z, et al. Early experience with pay-for- performance: from concept to practice [see comment]. JAMA. 2005;294: 1788 -1793
22. Barr JK, Giannotti TE, Sofaer S, et al. Using public reports of patient satisfaction for hospital quality improvement. Health Ser Res. 2006;41: 663-682
23. Hibbard JH, Stockard J, Tusler M. Hospital performance reports: impact on quality, market share, and reputation. Health Aff. 2005;24:1150-1160
24. Werner RM, Asch DA. The unintended consequences of publicly reporting quality information [see comment]. JAMA. 2005;293:1239-1244
25. Snyder C, Anderson G. Do quality improvement organizations improve the quality of hospital care for Medicare beneficiaries? [see comment]. JAMA. 2005;293:2900-2907
26. Harlan LC, Greene AL, Clegg LX, et al. Insurance status and the use of guideline therapy in the treatment of selected cancers [see comment]. J Clin Oncol. 2005;23:9079-9088
27. Hewitt ME, Simone JV, National Cancer Policy Board (US). Ensuring QualityCancer Care. Washington, DC: National Academy Press; 1999
28. Moher D, Schachter HM, Mamaladze V, et al. Measuring the quality of breast cancer care in women. Evidence Report: Technology Assessment (Summary). 2004;1-8
29. Winn RJ, Botnick WZ, Brown NH. The NCCN guideline program-1998. Oncology (Huntington). 1998;12:30-34
30. Winn RJ, Botnick W, Dozier N. The NCCN Guidelines Development Program. Oncology (Huntington). 1996;10:23-28
31. Senn HJ, Thurlimann B, Goldhirsch A, et al. Comments on the St. Gallen Consensus 2003 on the primary therapy of early breast cancer. Breast. 2003;12:569-582
32. Adjuvant Therapy for Breast Cancer. NIH Consens Statement. 2000. November 1-3;17:1-35
33. Malin JL, Schuster MA, Kahn KA, et al. Quality of breast cancer care: what do we know? J Clin Oncol. 2002;20:4381-4393
34. Du XL, Key CR, Osborne C, et al. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med. 2003;138:90-97.
35. Erratum: Ann Intern Med. 2003;139:873.
36. Summary for patients: Ann Intern Med. 2003;138:I16
37. Harlan LC, Abrams J, Warren JL, et al. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol. 2002; 20:1809-1817
38. Palazzi M, De Tomasi D, D'Affronto C, et al. Are international guidelines for the prescription of adjuvant treatment for early breast cancer followed in clinical practice? Results of a population-based study on 1547 patients. Tumori. 2002;88:503-506
39. NCCN: NCCN Clinical Practice Guidelines in Oncology. 1st ed. Jen- kintown, PA: The National Comprehensive Cancer Network; 2006. Available at: www.nccn.org
40. Weeks J, Niland J, Hughes ME, et al. Institutional Variation in Concordance with Guidelines for Breast Cancer Care in the National Comprehensive Cancer Network: Implications for Choice of Quality Indicators. Seattle, WA: Academy Health Annual Research Meeting; 2006
41. Weeks JC. Outcomes assessment in the NCCN. Oncology (Huntington). 1997;11:137-140
42. Niland JC. NCCN outcomes research database: data collection via the Internet. Oncology (Huntington). 2000;14:100-103
43. Weeks J. Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network. Oncology (Huntington). 1999;13:69-71
44. Christian CK, Niland J, Edge SB, et al. A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg. 2006;243:241-249
45. Adams K, Corrigan JM, Institute of Medicine (US): Priority areas for national action: transforming health care quality. Washington, DC: National Academies Press; 2003
46. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383
47. Katz JN, Chang LC, Sangha O, et al. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34: 73-84
48. Institute of Medicine (U.S.). Committee on the National Quality Report on Health Care Delivery. In: Hurtado MP, Swift EK, et al., eds. Envisioning the National Health Care Quality Report. Washington, DC: National Academy Press; 2001
49. Campbell SM, Braspenning J, Hutchinson A, et al. Research methods used in developing and applying quality indicators in primary care. BMJ. 2003;326:816 -819
50. Schneider EC, Epstein AM, Malin JL, et al. Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. J Clin Oncol. 2004;22:2985-2991
51. Quality and Performance in the NHS Performance Indicators. Department of Health UK; July 2000
52. Anonymous. Measuring the quality of breast cancer care in women. Evidence Report: Technology Assessment [Summary]. 2004;1-8